Immune modulation of paraneoplastic neurologic disorders.
Graus
F
F
Service of Neurology, Hospital Clinic i Provincial, Barcelona, Spain.
Delattre
J Y
JY
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015624:Lambert-Eaton Myasthenic Syndrome / Q000276:immunology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000276:immunology / Q000628:therapy*; D010257:Paraneoplastic Syndromes / Q000276:immunology / Q000628:therapy*; D011379:Prognosis
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents